Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Convertible Debt (2022 - 2025)

Historic Convertible Debt for Coeptis Therapeutics Holdings (COEPW) over the last 4 years, with Q3 2025 value amounting to $1.1 million.

  • Coeptis Therapeutics Holdings' Convertible Debt changed N/A to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $218750.0 for FY2024, which is 6500.0% down from last year.
  • According to the latest figures from Q3 2025, Coeptis Therapeutics Holdings' Convertible Debt is $1.1 million.
  • Coeptis Therapeutics Holdings' 5-year Convertible Debt high stood at $1.3 million for Q2 2025, and its period low was $58100.0 during Q3 2022.
  • Its 4-year average for Convertible Debt is $518336.9, with a median of $218750.0 in 2024.
  • Within the past 5 years, the most significant YoY rise in Coeptis Therapeutics Holdings' Convertible Debt was 6500.0% (2024), while the steepest drop was 6500.0% (2024).
  • Quarter analysis of 4 years shows Coeptis Therapeutics Holdings' Convertible Debt stood at $58100.0 in 2022, then skyrocketed by 975.73% to $625000.0 in 2023, then crashed by 65.0% to $218750.0 in 2024, then surged by 402.86% to $1.1 million in 2025.
  • Its Convertible Debt stands at $1.1 million for Q3 2025, versus $1.3 million for Q2 2025 and $218750.0 for Q1 2025.